Skip links

TVM Capital hosted its 10th Biennial Winter Conference
A Diary of a Great Networking Event in Kitzbuehel!

TVM Capital Life Science and TVM Capital Healthcare successfully convened the Group’s biennial Winter Conference with more than 150 attendants from Europe, the USA, Asia and the GCC representing global innovators of healthcare from the Venture Capital and Private Equity as well as the pharmaceutical and biotechnology industry, demonstrating their global footprint in innovative healthcare sectors like venture capital for therapy and product development and private equity for emerging markets targeting healthcare service innovation and manufacturing.

welcome note
Hubert Birner, TVM Capital Life Science – Welcome Note

TVM Capital, an affiliation of globally acting venture capital and private equity firms with an operating track record of more than 30 years, hosts this event since 1998 to provide a high-level networking and platform for strategic discussions with the firm’s global peers.

“Very much like the WEF in Davos.” —Hubert Birner, Managing Partner of TVM Capital Life Science

Darren Carroll, Senior Vice President, Corporate Business Development at Eli Lilly and Company, gave a ‘Perspective on External Innovation and New Models’ in his keynote speech, confirming that Lilly is “all in on innovation”.

darren-carroll
keyfactors

While a panel was focusing on ‘Key Factors of Success in Dealmaking in 2017′, (panelists: Darren Carroll, Lilly, Ute Lassnig, Evotec, Andre Turenne, Sanofi, Stephanie Leouzon, Torreya Partners, Luc Marengere, TVM Capital Life Science)  another discussion circled around the Key Factors of Success in the last 20 Years of company building and financing in the history of the firm.

The auditorium enjoyed a look into the future provided by Andrew Schwedel, Bain&Company and Greg Heibel, Partner at Orrick, who tried to ‘Predict the Future in Unpredictible Times’.

schwedel-heibel
big-data

The influence of Big Data technologies on healthcare was discussed as well as innovative therapies for neurogenerative diseases and rare diseases. Günther Schmidt, Definiens, Peter Neubeck, EXB Health, Dhavalmumar Patel, Novartis Venture Fund, Peter Bauer, Centogene, Daniel Parera, TVM Capital Life Science: ‘Big Data – Shaping the Future of Healthcare‘.

Several panels and talks focused on the differences in various geographies and how to bridge them with a global network of dedicated fund managers, advisors and innovators to ensure best possible access of patients to novel therapies and treatment. Christophe Bourrilly, MD Kronos Advisors, Joe Henein, CEO NewBridge Pharma, Helmut Schuehsler, TVM Capital Healthcare: ‘Pharma Outsourcing in Undercritical Geographies

pharma-outsourcing
healthcare-investing

Sarper Tanli, Group CEO Manzil Health, Sven Olaf Vathje, Partner, Oliver Wyman, Isabel Thywissen, Healthcare Expert, DEG, Ayman A. Khaleq, Partner, Morgan Lewis & Bockius, Helmut Schuehsler, TVM Capital Healthcare: ‘Driving Success in Healthcare Investing in the MENA Region & Emerging Markets.’

Neil Smith, VP R&D, Censa Pharma, Carlo Incerti, Head Global Medical Affairs, Sanofi, Arndt Rolf, CEO Centogene, Marc Riviere, TVM Capital Life Science: ‘Rare Diseases – Expanding Boundaries in Patient Care’.

patient-care
neurogenerative-deseases

Jacques Touchon, Prof. em. Universite de Montpellier, Guy Rouleau, Montreal Neurological Institute, Roger Nitzsch, Founder&President NeuroImmune, Konrad Glund, CEO Probiodrug, Robert Conley, Global Dev. Biomedicines, Eli Lilly, Marc Riviere, TVM Capital Life Science: ‘Perspectives on the Development of Drugs in Neurogenerative Diseases’.

Carl Stanifer, Group CEO Cambridge Medical & Rehabilitation Center, Ken Noonan, CEO, Lightstone,, Hui Hsing Ma, Senior Advisors SEA, TVM Capital Healthcare, Raymond Rudianto,Principal, BPEA, Hoda Abou-Jamra, TVM Capital Healthcare: ‘The Attractions of the SEA Healthcare Market for Investors’.

sea-healthcare-markets
schuehsler

Helmut Schuehsler, wrapped up, concluding that the next 10 years of Life Science Venture investing and Healthcare Private Equity investing will most probably be characterized by understanding how to provide innovative therapies on a truly international level and secondly how to regionally market these in undercritical geographies.

Hubert Birner and Luc Marengere, Managing Partners of TVM Capital Life Science, concluded the conference by thanking all attendants and especially the sponsors for making the event such an extraordinary experience with a professional program but also some fun activities such as a ski race on the famous slopes of the Kitzbuehel ski circus and a glamorous Gala Dinner at the Grandhotel in ‘Kitz’.

gala-dinner-2017
Headline Sponsor

piperjaffray

Gold Sponsors

Norton Rose FulbrightMorgan LewisOrickTorreya Partners

Should you be interested to learn more on any of the topics mentioned, please do not hesitate to contacts us. We look forward to hosting our next Winter Conference in February 2019!